1887

Abstract

Feline leukaemia virus (FeLV)-945 was previously identified in natural multicentric lymphomas and contains a 21 bp tandem triplication in the LTR. In the present study, FeLV LTR variation was examined in the cohort from which FeLV-945 was identified. The objectives of the study were to evaluate FeLV LTR variation within the cohort, to determine whether the FeLV-945 LTR was associated uniquely with multicentric lymphoma and to evaluate functional attributes that may have contributed selective advantage to the predominant LTR variants observed. T-cell tumours uniformly contained LTRs with duplicated enhancer sequences, although enhancer duplications conferred little transcriptional advantage. Non-T-cell malignant, proliferative and degenerative diseases contained LTRs with two, three or four tandemly repeated copies of the 21 bp sequence originally identified in FeLV-945. While the length and termini of enhancer duplications were variable, the 21 bp repeat unit was invariant. Triplication of the 21 bp repeat conferred the optimal replicative advantage in feline cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80149-0
2004-10-01
2019-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/10/vir852937.html?itemId=/content/journal/jgv/10.1099/vir.0.80149-0&mimeType=html&fmt=ahah

References

  1. Athas, G. B., Choi, B., Prabhu, S., Lobelle-Rich, P. A. & Levy, L. S. ( 1995a; ). Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 214, 431–438.[CrossRef]
    [Google Scholar]
  2. Athas, G. B., Lobelle-Rich, P. & Levy, L. S. ( 1995b; ). Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J Virol 69, 3324–3332.
    [Google Scholar]
  3. Donahue, P. R., Hoover, E. A., Beltz, G. A., Riedel, N., Hirsch, V. M., Overbaugh, J. & Mullins, J. I. ( 1988; ). Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol 62, 722–731.
    [Google Scholar]
  4. Fulton, R., Plumb, M., Shield, L. & Neil, J. C. ( 1990; ). Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol 64, 1675–1682.
    [Google Scholar]
  5. Jackson, M. L., Haines, D. M. & Misra, V. ( 1996; ). Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases. Vet Microbiol 53, 213–225.[CrossRef]
    [Google Scholar]
  6. Levesque, K. S., Bonham, L. & Levy, L. S. ( 1990; ). flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J Virol 64, 3455–3462.
    [Google Scholar]
  7. Matsumoto, Y., Momoi, Y., Watari, T., Goitsuka, R., Tsujimoto, H. & Hasegawa, A. ( 1992; ). Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology 189, 745–749.[CrossRef]
    [Google Scholar]
  8. Neil, J. C., Fulton, R., Rigby, M. & Stewart, M. ( 1991; ). Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr Top Microbiol Immunol 171, 67–93.
    [Google Scholar]
  9. Nishigaki, K., Endo, Y., Matsumoto, Y., Watari, T., Goitsuka, R., Tsujimoto, H. & Hasegata, A. ( 1997; ). Regulation of gene expression directed by the long terminal repeats of feline leukemia viruses. Leukemia 11 (Suppl. 3), 189–192.
    [Google Scholar]
  10. Nishigaki, K., Hanson, C., Thompson, D., Yugawa, T., Hisasue, M., Tsujimoto, H. & Ruscetti, S. ( 2002; ). Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus. J Virol 76, 1527–1532.[CrossRef]
    [Google Scholar]
  11. Overbaugh, J. & Bangham, C. R. ( 2001; ). Selection forces and constraints on retroviral sequence variation. Science 292, 1106–1109.[CrossRef]
    [Google Scholar]
  12. Plumb, M., Fulton, R., Breimer, L., Stewart, M., Willison, K. & Neil, J. C. ( 1991; ). Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines. J Virol 65, 1991–1999.
    [Google Scholar]
  13. Prabhu, S., Lobelle-Rich, P. A. & Levy, L. S. ( 1999; ). The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication. Virology 263, 460–470.[CrossRef]
    [Google Scholar]
  14. Rezanka, L. J., Rojko, J. L. & Neil, J. C. ( 1992; ). Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest 10, 371–389.[CrossRef]
    [Google Scholar]
  15. Starkey, C. R., Lobelle-Rich, P. A., Granger, S., Brightman, B. K., Fan, H. & Levy, L. S. ( 1998; ). Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus. J Virol 72, 1078–1084.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80149-0
Loading
/content/journal/jgv/10.1099/vir.0.80149-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error